NCT04345081

Brief Summary

This is a response-adaptive (RAR) prospective randomized study with a long-term follow-up and the aim of this clinical study is to measure with qualitative and quantitative indicators the changes in cosmetic results, quality of life and patient satisfaction after delayed- immediate breast reconstruction with standardized technique Skin Reducing Nipple sparing mastectomy, SRNSM and SSM with standardized horizontal skin incision. According to our hypothesis, SRNSM with standardized technique on pendulous/ ptotic breasts is a safe procedure compared to SSM. It also promotes the cosmetic efficacy of SRNSM with the removal of the entire glandular tissue through avoidance of the reduction of projection, the need later nipple reconstruction surgery and of areola tattoo. In our study we propose that compared to one of the well-known and widely investigated studied SSM, our current standardized SRNSM technique is able to perform similar oncologically safe entire gland tissue removal, with low complication rate, accommodating for adjuvant treatments. Furthermore, it may provide superior cosmetic results than SSM (NAC is not removed, projection is maintained, and there is no need for further nipple reconstruction or tattoo) with high patient satisfaction which is maintained long term.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for all trials

Timeline
11mo left

Started Apr 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Apr 2020Apr 2027

First Submitted

Initial submission to the registry

April 5, 2020

Completed
9 days until next milestone

First Posted

Study publicly available on registry

April 14, 2020

Completed
4 days until next milestone

Study Start

First participant enrolled

April 18, 2020

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 5, 2022

Completed
5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 5, 2027

Expected
Last Updated

April 21, 2020

Status Verified

April 1, 2020

Enrollment Period

2 years

First QC Date

April 5, 2020

Last Update Submit

April 18, 2020

Conditions

Outcome Measures

Primary Outcomes (4)

  • Oncological safety

    Using correlation analysis to measure objective changes and the changes over time in oncological control achieved by different surgical techniques

    five years of follow-up

  • Patients' satisfaction

    Using correlation analysis to measure objective changes and the changes over time in patients' satisfaction achieved by different surgical techniques

    five years of follow-up

  • Cosmetic results

    Using correlation analysis to measure objective changes and the changes over time in cosmetic results achieved by different surgical techniques

    five years of follow-up

  • Quality of life

    Using correlation analysis to measure objective changes and the changes over time in quality of life achieved by different surgical techniques

    five years of follow-up

Secondary Outcomes (1)

  • Complications rate

    five years of follow-up

Study Arms (2)

SRNSM Group

Under the age of 65 with uni- or bilateral primary breast cancer ( clinical Stage 0-III), needing skin sparing mastectomy, nipple sparing mastectomy or patients require risk reducing mastectomy independently of the axillary surgery, having immediate or delayed-immediate implant based reconstruction. This Group receive Skin Reducing Nipple Sparing Mastectomy

Procedure: Skin Reducing Nipple Sparing Mastectomy and Implant Based Breast Reconstruction

SSM Group

Under the age of 65 with uni- or bilateral primary breast cancer ( clinical Stage 0-III), needing skin sparing mastectomy, nipple sparing mastectomy or patients require risk reducing mastectomy independently of the axillary surgery, having immediate or delayed-immediate implant based reconstruction. This Group receive Skin Sparing Mastectomy

Procedure: Skin- Sparing Mastectomy and Implant- Based Breast Reconstructive Surgery

Interventions

Skin Reducing Nipple Sparing Mastectomy is performed from Inverted T incisuion and nipple is preserved.

SRNSM Group

Classic Skin- Sparing Mastectomy

SSM Group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The aim of the clinical study is to measure with a long-term follow-up and with qualitative and quantitative indicators the changes in cosmetic results, quality of life and patient satisfaction after delayed- immediate breast reconstruction with standardized technique Skin Reducing Nipple sparing mastectomy, SRNSM and SSM. The planned subgroups contain 50-50 cases. Planned number of patients (calculated patients' number plus 10%): 50x2=100 +10 cases * 110 cases should be included.

You may qualify if:

  • Under the age of 65 with uni- or bilateral primary breast cancer ( clinical Stage 0-III), needing skin sparing mastectomy, nipple sparing mastectomy or patients require risk reducing mastectomy independently of the axillary surgery, having immediate or delayed-immediate implant based reconstruction.

You may not qualify if:

  • In case the patient does not volunteer for the examination or the follow-ups
  • Age above 65 years or poor general health condition, where the estimated life expectancies would be less than 2 years even without the tumorous disease
  • Malignant invasive tumor in the past history (except for non-melanoma skin tumors)
  • Mastectomy and reconstruction performed due pregnancy associated breast cancer
  • Prior breast surgery (e.g. aesthetic surgery, mastopexy) and/or radiotherapy on the breast or in the axilla
  • Malignant tumor is not removed completely with pathological examination
  • Severe non-surgical (e.g. radiotherapy) complication, which could influence the aesthetic and functional results
  • Autoimmune diseases
  • Mastitis carcinomatosa
  • Lymphangitis carcinomatosa
  • Open wound therapy due SSI
  • Long-term steroid usage, which changed the skin's quality and structure
  • Patient under foster care, or psychically non-cooperative patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Institute of Oncology

Budapest, 1122, Hungary

RECRUITING

Related Publications (15)

  • Galimberti V, Vicini E, Corso G, Morigi C, Fontana S, Sacchini V, Veronesi P. Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications. Breast. 2017 Aug;34 Suppl 1(Suppl 1):S82-S84. doi: 10.1016/j.breast.2017.06.034. Epub 2017 Jun 30.

    PMID: 28673535BACKGROUND
  • Murthy V, Chamberlain RS. Defining a place for nipple sparing mastectomy in modern breast care: an evidence based review. Breast J. 2013 Nov-Dec;19(6):571-81. doi: 10.1111/j.1524-4741.2011.01220.x. Epub 2012 Jan 29.

    PMID: 22284266BACKGROUND
  • Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjo T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blattler U, Gunthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M. Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy. Breast Cancer Res Treat. 2018 Dec;172(3):523-537. doi: 10.1007/s10549-018-4937-1. Epub 2018 Sep 4.

    PMID: 30182349BACKGROUND
  • Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000 Sep 6;92(17):1422-9. doi: 10.1093/jnci/92.17.1422.

    PMID: 10974078BACKGROUND
  • Fang SY, Shu BC, Chang YJ. The effect of breast reconstruction surgery on body image among women after mastectomy: a meta-analysis. Breast Cancer Res Treat. 2013 Jan;137(1):13-21. doi: 10.1007/s10549-012-2349-1. Epub 2012 Dec 6.

    PMID: 23225142BACKGROUND
  • Djohan R, Gage E, Gatherwright J, Pavri S, Firouz J, Bernard S, Yetman R. Patient satisfaction following nipple-sparing mastectomy and immediate breast reconstruction: an 8-year outcome study. Plast Reconstr Surg. 2010 Mar;125(3):818-29. doi: 10.1097/PRS.0b013e3181ccdaa4.

    PMID: 20195110BACKGROUND
  • Morigi C. Highlights from the 15th St Gallen International Breast Cancer Conference 15-18 March, 2017, Vienna: tailored treatments for patients with early breast cancer. Ecancermedicalscience. 2017 Apr 7;11:732. doi: 10.3332/ecancer.2017.732. eCollection 2017.

    PMID: 28491135BACKGROUND
  • Kontos M, Lanitis S, Constantinidou A, Sakarellos P, Vagios E, Tampaki EC, Tampakis A, Fragoulis M. Nipple-sparing skin-reducing mastectomy with reconstruction for large ptotic breasts. J Plast Reconstr Aesthet Surg. 2020 Apr;73(4):690-695. doi: 10.1016/j.bjps.2019.11.025. Epub 2019 Nov 28.

    PMID: 31928958BACKGROUND
  • Falco G, Curcio A, Marongiu F, Buggi F, Mingozzi M, Mele S, Ferrari G, Folli S. Bipedicled Nipple-Sparing Mastectomy Versus Traditional Nipple-Sparing Mastectomy: Comparison of 2 Alternative Techniques in Order to Save Nipple-Areola Complex. Ann Plast Surg. 2020 Apr;84(4):366-374. doi: 10.1097/SAP.0000000000002166.

    PMID: 31850968BACKGROUND
  • Rosenberger WF, Sverdlov O, Hu F. Adaptive randomization for clinical trials. J Biopharm Stat. 2012;22(4):719-36. doi: 10.1080/10543406.2012.676535.

    PMID: 22651111BACKGROUND
  • Pusic AL, Klassen AF, Scott AM, Klok JA, Cordeiro PG, Cano SJ. Development of a new patient-reported outcome measure for breast surgery: the BREAST-Q. Plast Reconstr Surg. 2009 Aug;124(2):345-353. doi: 10.1097/PRS.0b013e3181aee807.

    PMID: 19644246BACKGROUND
  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004 Aug;240(2):205-13. doi: 10.1097/01.sla.0000133083.54934.ae.

    PMID: 15273542BACKGROUND
  • Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, de Santibanes E, Pekolj J, Slankamenac K, Bassi C, Graf R, Vonlanthen R, Padbury R, Cameron JL, Makuuchi M. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009 Aug;250(2):187-96. doi: 10.1097/SLA.0b013e3181b13ca2.

    PMID: 19638912BACKGROUND
  • Dikmans REG, Nene LEH, Bouman MB, de Vet HCW, Mureau MAM, Buncamper ME, Winters HAH, Ritt MJPF, Mullender MG. The Aesthetic Items Scale: A Tool for the Evaluation of Aesthetic Outcome after Breast Reconstruction. Plast Reconstr Surg Glob Open. 2017 Mar 1;5(3):e1254. doi: 10.1097/GOX.0000000000001254. eCollection 2017 Mar.

    PMID: 28458968BACKGROUND
  • Mátrai Z, Gulyás G, Kovács T, et al. Principles and practice of oncoplastic breast surgery. Medicina Kiadó; 2019.

    BACKGROUND

MeSH Terms

Conditions

Breast NeoplasmsLymphedemaPatient Satisfaction

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesLymphatic DiseasesHemic and Lymphatic DiseasesTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Surgical Oncology

Study Record Dates

First Submitted

April 5, 2020

First Posted

April 14, 2020

Study Start

April 18, 2020

Primary Completion

April 5, 2022

Study Completion (Estimated)

April 5, 2027

Last Updated

April 21, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations